Use of organs from hepatitis C virus positive donors for uninfected recipients: a potential cost-effective approach to save lives?

Background Organs from hepatitis C virus (HCV) seropositive (HCVpos) individuals are seldom used for transplantation because of the risk of disease transmission. Because transmitted HCV is now amenable to effective treatment we estimated the potential impact of using HCVpos deceased donor organs for transplantation. Methods The Potential Donor Audit (PDA) of patients (

http://ift.tt/2jLJMOF